2019 EACTS Expert Consensus on long-term mechanical circulatory support
Tóm tắt
Long-term mechanical circulatory support (LT-MCS) is an important treatment modality for patients with severe heart failure. Different devices are available, and many—sometimes contradictory—observations regarding patient selection, surgical techniques, perioperative management and follow-up have been published. With the growing expertise in this field, the European Association for Cardio-Thoracic Surgery (EACTS) recognized a need for a structured multidisciplinary consensus about the approach to patients with LT-MCS. However, the evidence published so far is insufficient to allow for generation of meaningful guidelines complying with EACTS requirements. Instead, the EACTS presents an expert opinion in the LT-MCS field. This expert opinion addresses patient evaluation and preoperative optimization as well as management of cardiac and non-cardiac comorbidities. Further, extensive operative implantation techniques are summarized and evaluated by leading experts, depending on both patient characteristics and device selection. The faculty recognized that postoperative management is multidisciplinary and includes aspects of intensive care unit stay, rehabilitation, ambulatory care, myocardial recovery and end-of-life care and mirrored this fact in this paper. Additionally, the opinions of experts on diagnosis and management of adverse events including bleeding, cerebrovascular accidents and device malfunction are presented. In this expert consensus, the evidence for the complete management from patient selection to end-of-life care is carefully reviewed with the aim of guiding clinicians in optimizing management of patients considered for or supported by an LT-MCS device.
Từ khóa
Tài liệu tham khảo
2017
Mehra, 2018, Two-year outcomes with a magnetically levitated cardiac pump in heart failure, N Engl J Med, 378, 1386, 10.1056/NEJMoa1800866
Morshuis, 2018, Clinical outcomes with HeartMate 3TM left ventricular assist device as treatment for advanced heart failure: 12-month outcomes from the ELEVATE Registry, J Heart Lung Transplant, 37, S84., 10.1016/j.healun.2018.01.193
Kirklin, 2016, First annual IMACS report: a global International Society for Heart and Lung Transplantation Registry for mechanical circulatory support, J Heart Lung Transplant, 35, 407, 10.1016/j.healun.2016.01.002
Baras Shreibati, 2017, Cost-effectiveness of left ventricular assist devices in ambulatory patients with advanced heart failure, JACC Heart Fail, 5, 110, 10.1016/j.jchf.2016.09.008
Rogers, 2012, Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy, Circ Heart Fail, 5, 10, 10.1161/CIRCHEARTFAILURE.111.962951
Tsiouris, 2014, Factors determining post-operative readmissions after left ventricular assist device implantation, J Heart Lung Transplant, 33, 1041, 10.1016/j.healun.2014.05.009
Bruce, 2017, Caregivers of patients with left ventricular assist devices: possible impacts on patients' mortality and Interagency Registry for Mechanically Assisted Circulatory Support-defined morbidity events, Circ Cardiovasc Qual Outcomes, 10, 1, 10.1161/CIRCOUTCOMES.116.002879
Lund, 2018, Optimizing outcomes after heart transplantation, Eur J Heart Fail, 20, 395, 10.1002/ejhf.1026
Ponikowski, 2016, 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC, Eur J Heart Fail, 18, 891, 10.1002/ejhf.592
Stevenson, 2009, INTERMACS profiles of advanced heart failure: the current picture, J Heart Lung Transplant, 28, 535, 10.1016/j.healun.2009.02.015
den Uil, 2017, Short-term mechanical circulatory support as a bridge to durable left ventricular assist device implantation in refractory cardiogenic shock: a systematic review and meta-analysis, Eur J Cardiothorac Surg, 52, 14, 10.1093/ejcts/ezx088
Shah, 2017, Outcomes of patients receiving temporary circulatory support before durable ventricular assist device, Ann Thorac Surg, 103, 106, 10.1016/j.athoracsur.2016.06.002
Rahimi, 2014, Risk prediction in patients with heart failure: a systematic review and analysis, JACC Heart Fail, 2, 440, 10.1016/j.jchf.2014.04.008
Ouwerkerk, 2014, Factors influencing the predictive power of models for predicting mortality and/or heart failure hospitalization in patients with heart failure, JACC Heart Fail, 2, 429, 10.1016/j.jchf.2014.04.006
Ravichandran, 2015, Left ventricular assist device patient selection: do risk scores help?, J Thorac Dis, 7, 2080
Lund, 2016, Risk scores and biomarkers in heart failure: a journey to predictive accuracy and clinical utility, J Heart Lung Transplant, 35, 711, 10.1016/j.healun.2016.04.003
Mehra, 2016, The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: a 10-year update, J Heart Lung Transplant, 35, 1, 10.1016/j.healun.2015.10.023
Wright, 2015, Marital status and survival in left ventricular assist device patient populations, J Heart Lung Transplant, 34, 619, 10.1016/j.healun.2014.11.016
Cowger, 2017, Impact of center left ventricular assist device volume on outcomes after implantation: an INTERMACS analysis, JACC Heart Fail, 5, 691, 10.1016/j.jchf.2017.05.011
Zabarovskaja, 2013, Identifying patients for advanced heart failure therapy by screening patients with cardiac resynchronization therapy or implantable cardioverter-defibrillator: a pilot study, J Heart Lung Transplant, 32, 651, 10.1016/j.healun.2013.02.008
Pocock, 2006, Predictors of mortality and morbidity in patients with chronic heart failure, Eur Heart J, 27, 65, 10.1093/eurheartj/ehi555
Cotts, 2014, Predictors of hospital length of stay after implantation of a left ventricular assist device: an analysis of the INTERMACS Registry, J Heart Lung Transplant, 33, 682, 10.1016/j.healun.2014.02.022
Adamson, 2011, Clinical strategies and outcomes in advanced heart failure patients older than 70 years of age receiving the HeartMate II left ventricular assist device: a community hospital experience, J Am Coll Cardiol, 57, 2487, 10.1016/j.jacc.2011.01.043
Kirklin, 2015, Seventh INTERMACS annual report: 15,000 patients and counting, J Heart Lung Transplant, 34, 1495, 10.1016/j.healun.2015.10.003
Kusne, 2017, An ISHLT consensus document for prevention and management strategies for mechanical circulatory support infection, J Heart Lung Transplant, 36, 1137, 10.1016/j.healun.2017.06.007
Sims, 2011, Human immunodeficiency virus infection and left ventricular assist devices: a case series, J Heart Lung Transplant, 30, 1060, 10.1016/j.healun.2011.03.004
Butler, 2005, Diabetes and outcomes after left ventricular assist device placement, J Card Fail, 11, 510, 10.1016/j.cardfail.2005.05.003
Topkara, 2005, Effect of diabetes on short- and long-term outcomes after left ventricular assist device implantation, J Heart Lung Transplant, 24, 2048, 10.1016/j.healun.2005.06.021
Uriel, 2011, Improved diabetic control in advanced heart failure patients treated with left ventricular assist devices, Eur J Heart Fail, 13, 195, 10.1093/eurjhf/hfq204
Lofman, 2017, Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction, Eur J Heart Fail, 19, 1606, 10.1002/ejhf.821
Smith, 2006, Renal impairment and outcomes in heart failure: systematic review and meta-analysis, J Am Coll Cardiol, 47, 1987, 10.1016/j.jacc.2005.11.084
Gustafsson, 2017, Left ventricular assist device therapy in advanced heart failure: patient selection and outcomes, Eur J Heart Fail, 19, 595, 10.1002/ejhf.779
Topkara, 2016, Preoperative proteinuria and reduced glomerular filtration rate predicts renal replacement therapy in patients supported with continuous-flow left ventricular assist devices, Circ Heart Fail, 9, 1, 10.1161/CIRCHEARTFAILURE.115.002897
Klovaite, 2009, Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II), J Am Coll Cardiol, 53, 2162, 10.1016/j.jacc.2009.02.048
Starling, 2014, Unexpected abrupt increase in left ventricular assist device thrombosis, N Engl J Med, 370, 33, 10.1056/NEJMoa1313385
Slaughter, 2010, Clinical management of continuous-flow left ventricular assist devices in advanced heart failure, J Heart Lung Transplant, 29, 1, 10.1016/j.healun.2010.01.011
Demirozu, 2011, Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device, J Heart Lung Transplant, 30, 849
Holley, 2017, Aortic insufficiency in continuous-flow left ventricular assist device support patients is common but does not impact long-term mortality, J Heart Lung Transplant, 36, 91, 10.1016/j.healun.2016.07.018
Pal, 2009, Low operative mortality with implantation of a continuous-flow left ventricular assist device and impact of concurrent cardiac procedures, Circulation, 120, S215, 10.1161/CIRCULATIONAHA.108.844274
Yang, 2012, Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system, J Heart Lung Transplant, 31, 601, 10.1016/j.healun.2012.02.027
Cermakova, 2015, Heart failure and dementia: survival in relation to types of heart failure and different dementia disorders, Eur J Heart Fail, 17, 612, 10.1002/ejhf.222
Kato, 2012, Pre-operative and post-operative risk factors associated with neurologic complications in patients with advanced heart failure supported by a left ventricular assist device, J Heart Lung Transplant, 31, 1, 10.1016/j.healun.2011.08.014
Flint, 2012, Frailty and the selection of patients for destination therapy left ventricular assist device, Circ Heart Fail, 5, 286, 10.1161/CIRCHEARTFAILURE.111.963215
Moayedi, 2018, The prognostic significance of frailty compared to peak oxygen consumption and B-type natriuretic peptide in patients with advanced heart failure, Clin Transplant, 32, 1, 10.1111/ctr.13158
Jha, 2015, Frailty in advanced heart failure: a systematic review, Heart Fail Rev, 20, 553, 10.1007/s10741-015-9493-8
Tse, 2018, Frailty and clinical outcomes in advanced heart failure patients undergoing left ventricular assist device implantation: a systematic review and meta-analysis, J Am Med Dir Assoc, 19, 255, 10.1016/j.jamda.2017.09.022
Dunlay, 2014, Frailty and outcomes after implantation of left ventricular assist device as destination therapy, J Heart Lung Transplant, 33, 359, 10.1016/j.healun.2013.12.014
Reynard, 2014, Frequency of depression and anxiety before and after insertion of a continuous flow left ventricular assist device, Am J Cardiol, 114, 433, 10.1016/j.amjcard.2014.05.015
Cupples, 2006, Report of the Psychosocial Outcomes Workgroup of the Nursing and Social Sciences Council of the International Society for Heart and Lung Transplantation: present status of research on psychosocial outcomes in cardiothoracic transplantation: review and recommendations for the field, J Heart Lung Transplant, 25, 716, 10.1016/j.healun.2006.02.005
Eshelman, 2009, LVAD destination therapy: applying what we know about psychiatric evaluation and management from cardiac failure and transplant, Heart Fail Rev, 14, 21, 10.1007/s10741-007-9075-5
Kaan, 2010, Emotional experiences of caregivers of patients with a ventricular assist device, Prog Transplant, 20, 142, 10.1177/152692481002000208
Bunzel, 2007, Mechanical circulatory support as a bridge to heart transplantation: what remains? Long-term emotional sequelae in patients and spouses, J Heart Lung Transplant, 26, 384, 10.1016/j.healun.2007.01.025
Lund, 2010, Patient selection for left ventricular assist devices, Eur J Heart Fail, 12, 434, 10.1093/eurjhf/hfq006
Schibilsky, 2017, Extracorporeal life support prior to left ventricular assist device implantation leads to improvement of the patients INTERMACS levels and outcome, PLoS One, 12, 1, 10.1371/journal.pone.0174262
Kirklin, 2013, Quantifying the effect of cardiorenal syndrome on mortality after left ventricular assist device implant, J Heart Lung Transplant, 32, 1205, 10.1016/j.healun.2013.09.001
Kim, 2016, Ventricular assist device therapy in older patients with heart failure: characteristics and outcomes, J Card Fail, 22, 981, 10.1016/j.cardfail.2016.10.004
Patil, 2015, Preoperative predictors and outcomes of right ventricular assist device implantation after continuous-flow left ventricular assist device implantation, J Thorac Cardiovasc Surg, 150, 1651, 10.1016/j.jtcvs.2015.07.090
Maltais, 2016, Right and left ventricular assist devices support and liver dysfunction: prognostic and therapeutic implications, Curr Opin Cardiol, 31, 287, 10.1097/HCO.0000000000000288
Pappalardo, 2016, Hemodynamic and echocardiographic effects of aortic regurgitation on femoro-femoral veno-arterial ECMO, Int J Cardiol, 202, 760, 10.1016/j.ijcard.2015.10.062
Boulate, 2013, Acute lung injury after mechanical circulatory support implantation in patients on extracorporeal life support: an unrecognized problem, Eur J Cardiothorac Surg, 44, 544, 10.1093/ejcts/ezt125
Pappalardo, 2017, Concomitant implantation of Impella((R)) on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock, Eur J Heart Fail, 19, 404, 10.1002/ejhf.668
Matthews, 2010, Model for end-stage liver disease score predicts left ventricular assist device operative transfusion requirements, morbidity, and mortality, Circulation, 121, 214, 10.1161/CIRCULATIONAHA.108.838656
Pagano, 2018, 2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery, Eur J Cardiothorac Surg, 53, 79, 10.1093/ejcts/ezx325
Dang, 2005, Nutritional status in patients on left ventricular assist device support, J Thorac Cardiovasc Surg, 130, e3, 10.1016/j.jtcvs.2005.07.038
Holdy, 2005, Nutrition assessment and management of left ventricular assist device patients, J Heart Lung Transplant, 24, 1690, 10.1016/j.healun.2004.11.047
Kirklin, 2017, Eighth annual INTERMACS report: special focus on framing the impact of adverse events, J Heart Lung Transplant, 36, 1080, 10.1016/j.healun.2017.07.005
Jorde, 2014, Prevalence, significance, and management of aortic insufficiency in continuous flow left ventricular assist device recipients, Circ Heart Fail, 7, 310, 10.1161/CIRCHEARTFAILURE.113.000878
Robertson, 2015, Concomitant aortic valve procedures in patients undergoing implantation of continuous-flow left ventricular assist devices: an INTERMACS database analysis, J Heart Lung Transplant, 34, 797, 10.1016/j.healun.2014.11.008
Fukuhara, 2017, Concomitant repair for mild aortic insufficiency and continuous-flow left ventricular assist devices, Eur J Cardiothorac Surg, 52, 1062, 10.1093/ejcts/ezx150
Feldman, 2013, The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary, J Heart Lung Transplant, 32, 157, 10.1016/j.healun.2012.09.013
Stainback, 2015, Echocardiography in the management of patients with left ventricular assist devices: recommendations from the American Society of Echocardiography, J Am Soc Echocardiogr, 28, 853, 10.1016/j.echo.2015.05.008
Tanaka, 2017, Surgically corrected mitral regurgitation during left ventricular assist device implantation is associated with low recurrence rate and improved midterm survival, Ann Thorac Surg, 103, 725, 10.1016/j.athoracsur.2016.06.078
Sandoval, 2017, Impact of concomitant mitral valve repair for severe mitral regurgitation at the time of continuous-flow left ventricular assist device insertion, Interact CardioVasc Thorac Surg, 25, 620, 10.1093/icvts/ivx223
Robertson, 2018, Concomitant mitral valve procedures in patients undergoing implantation of continuous-flow left ventricular assist devices: an INTERMACS database analysis, J Heart Lung Transplant, 37, 79, 10.1016/j.healun.2017.09.016
Dandel, 2015, Left ventricular vs. biventricular mechanical support: decision-making and strategies for avoidance of right heart failure after left ventricular assist device implantation, Int J Cardiol, 198, 241, 10.1016/j.ijcard.2015.06.103
Brewer, 2014, Relationship of tricuspid repair at the time of left ventricular assist device implantation and survival, Int J Artif Organs, 37, 834, 10.5301/ijao.5000369
Robertson, 2014, Concomitant tricuspid valve surgery during implantation of continuous-flow left ventricular assist devices: a Society of Thoracic Surgeons database analysis, J Heart Lung Transplant, 33, 609, 10.1016/j.healun.2014.01.861
Kirchhof, 2016, 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS, Eur J Cardiothorac Surg, 50, e1, 10.1093/ejcts/ezw313
Song, 2016, Limited utility of tricuspid valve repair at the time of left ventricular assist device implantation, Ann Thorac Surg, 101, 2168, 10.1016/j.athoracsur.2016.03.040
Bartfay, 2017, Are biventricular assist devices underused as a bridge to heart transplantation in patients with a high risk of postimplant right ventricular failure?, J Thorac Cardiovasc Surg, 153, 360, 10.1016/j.jtcvs.2016.09.084
Maury, 2010, First experience of percutaneous radio-frequency ablation for atrial flutter and atrial fibrillation in a patient with HeartMate II left ventricular assist device, J Interv Card Electrophysiol, 29, 63, 10.1007/s10840-010-9476-6
Calkins, 2017, 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary, Heart Rhythm, 14, e445, 10.1016/j.hrthm.2017.07.009
Clerkin, 2017, Implantable cardioverter-defibrillators in patients with a continuous-flow left ventricular assist device: an analysis of the INTERMACS Registry, JACC Heart Fail, 5, 916, 10.1016/j.jchf.2017.08.014
Boudghene-Stambouli, 2014, Clinical implications of left ventricular assist device implantation in patients with an implantable cardioverter-defibrillator, J Interv Card Electrophysiol, 39, 177, 10.1007/s10840-013-9854-y
Mulloy, 2013, Cryoablation during left ventricular assist device implantation reduces postoperative ventricular tachyarrhythmias, J Thorac Cardiovasc Surg, 145, 1207, 10.1016/j.jtcvs.2012.03.061
Patel, 2016, Safety and feasibility of open chest epicardial mapping and ablation of ventricular tachycardia during the period of left ventricular assist device implantation, J Cardiovasc Electrophysiol, 27, 95, 10.1111/jce.12839
Friedman, 2018, Association between left atrial appendage occlusion and readmission for thromboembolism among patients with atrial fibrillation undergoing concomitant cardiac surgery, JAMA, 319, 365, 10.1001/jama.2017.20125
Ozbaran, 2016, Left ventricular assist device implantation by lateral thoracotomy to the descending aorta: a propensity matched analysis to standard sternotomy approach, J Heart Lung Transplant, 35, S322., 10.1016/j.healun.2016.01.919
Chou, 2017, Permanent continuous flow left ventricular assist devices use after acute stabilization for cardiogenic shock in acute myocardial infarction, ASAIO J, 63, e13, 10.1097/MAT.0000000000000398
De By, 2018, The European Registry for Patients with Mechanical Circulatory Support (EUROMACS) of the European Association for Cardio-Thoracic Surgery (EACTS): second report, Eur J Cardiothorac Surg, 53, 309, 10.1093/ejcts/ezx320
Kirklin, 2018, Second annual report from the ISHLT Mechanically Assisted Circulatory Support Registry, J Heart Lung Transplant, 37, 685, 10.1016/j.healun.2018.01.1294
Sigurdardottir, 2012, Long-term follow-up of lung and heart transplant recipients with pre-transplant malignancies, J Heart Lung Transplant, 31, 1276, 10.1016/j.healun.2012.09.007
Cooper, 2018, Assessing frailty in patients undergoing destination therapy left ventricular assist device: observations from Interagency Registry for Mechanically Assisted Circulatory Support, ASAIO J, 64, 16, 10.1097/MAT.0000000000000600
Joseph, 2017, Prospective assessment of frailty using the fried criteria in patients undergoing left ventricular assist device therapy, Am J Cardiol, 120, 1349, 10.1016/j.amjcard.2017.07.074
Maurer, 2017, Can a left ventricular assist device in individuals with advanced systolic heart failure improve or reverse frailty?, J Am Geriatr Soc, 65, 2383, 10.1111/jgs.15124
Lushaj, 2015, Impact of age on outcomes following continuous-flow left ventricular assist device implantation, Interact CardioVasc Thorac Surg, 20, 743, 10.1093/icvts/ivv051
Morgan, 2014, Should left ventricular assist devices be implanted in patients seventy years of age and older: a comparative analysis, Heart Surg Forum, 17, 182, 10.1532/HSF98.2014386
Loncar, 2016, Cardiac cachexia: hic et nunc, J Cachexia Sarcopenia Muscle, 7, 246, 10.1002/jcsm.12118
Flint, 2013, Pre-operative health status and outcomes after continuous-flow left ventricular assist device implantation, J Heart Lung Transplant, 32, 1249, 10.1016/j.healun.2013.09.005
Yost, 2018, Preoperative nutritional assessment with the prognostic nutrition index in patients undergoing left ventricular assist device implantation, ASAIO J, 64, 52, 10.1097/MAT.0000000000000625
Patel, 2013, Renal failure in patients with left ventricular assist devices, Clin J Am Soc Nephrol, 8, 484, 10.2215/CJN.06210612
Bhat, 2015, Cognitive function and left ventricular assist device implantation, J Heart Lung Transplant, 34, 1398, 10.1016/j.healun.2015.05.015
Maldonado, 2015, The Stanford Integrated Psychosocial Assessment for Transplantation: a prospective study of medical and psychosocial outcomes, Psychosom Med, 77, 1018, 10.1097/PSY.0000000000000241
Vandenbogaart, 2017, Evaluation of the SIPAT instrument to assess psychosocial risk in heart transplant candidates: a retrospective single center study, Heart Lung, 46, 273, 10.1016/j.hrtlng.2017.04.005
Mikus, 2011, Left ventricular assist device or heart transplantation: impact of transpulmonary gradient and pulmonary vascular resistance on decision-making, Eur J Cardiothorac Surg, 39, 310, 10.1016/j.ejcts.2010.05.031
Beyersdorf, 2010, Regression of “fixed” pulmonary vascular resistance in heart transplant candidates after unloading with ventricular assist devices, J Thorac Cardiovasc Surg, 140, 747, 10.1016/j.jtcvs.2010.05.042
Salzberg, 2005, Normalization of high pulmonary vascular resistance with LVAD support in heart transplantation candidates, Eur J Cardiothorac Surg, 27, 222, 10.1016/j.ejcts.2004.11.001
Stathatos, 2003, The euthyroid sick syndrome: is there a physiologic rationale for thyroid hormone treatment?, J Endocrinol Invest, 26, 1174, 10.1007/BF03349153
Carrel, 2002, Thyronin treatment in adult and pediatric heart surgery: clinical experience and review of the literature, Eur J Heart Fail, 4, 577, 10.1016/S1388-9842(02)00096-X
Vest, 2016, Outcomes for patients with diabetes after continuous-flow left ventricular assist device implantation, J Card Fail, 22, 780, 10.1016/j.cardfail.2016.02.010
Mohamedali, 2017, Is diabetes mellitus a risk factor for poor prognosis after left ventricular assist device placement?, Tex Heart Inst J, 44, 115, 10.14503/THIJ-15-5698
Mohamedali, 2014, Mechanical circulatory support improves diabetic control in patients with advanced heart failure, Eur J Heart Fail, 16, 1120, 10.1002/ejhf.166
van den Berge, 2018, Short- and long-term prognosis of patients with acute heart failure with and without diabetes: changes over the last three decades, Diabetes Care, 41, 143, 10.2337/dc17-0544
Bhat, 2013, Cardiology and Cardiovascular Medicine: Recent Advances in the Field of Ventricular Assist Devices
Uriel, 2010, Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation, J Am Coll Cardiol, 56, 1207, 10.1016/j.jacc.2010.05.016
Mohacsi, 1994, Hypoxic hepatitis in patients with cardiac failure, J Hepatol, 21, 693, 10.1016/S0168-8278(94)80225-4
Gelow, 2010, Clinical predictors of hepatic fibrosis in chronic advanced heart failure, Circ Heart Fail, 3, 59, 10.1161/CIRCHEARTFAILURE.109.872556
Modi, 2010, Do patients with liver cirrhosis undergoing cardiac surgery have acceptable outcomes?, Interact CardioVasc Thorac Surg, 11, 630, 10.1510/icvts.2010.241190
Potthoff, 2015, Liver stiffness measurements and short-term survival after left ventricular assist device implantation: a pilot study, J Heart Lung Transplant, 34, 1586, 10.1016/j.healun.2015.05.022
Demirozu, 2014, HeartMate II left ventricular assist device implantation in patients with advanced hepatic dysfunction, J Card Surg, 29, 419, 10.1111/jocs.12318
Amione-Guerra, 2017, Melding a high-risk patient for continuous flow left ventricular assist device into a low-risk patient, ASAIO J, 63, 704, 10.1097/MAT.0000000000000591
Deo, 2013, Predictive value of the model for end-stage liver disease score in patients undergoing left ventricular assist device implantation, ASAIO J, 59, 57, 10.1097/MAT.0b013e31827c0c77
Nishi, 2013, Prediction of outcome in patients with liver dysfunction after left ventricular assist device implantation, J Artif Organs, 16, 404, 10.1007/s10047-013-0724-2
Weymann, 2015, Continuous-flow left ventricular assist device therapy in patients with preoperative hepatic failure: are we pushing the limits too far?, Artif Organs, 39, 336, 10.1111/aor.12375
Woolley, 2015, Preoperative liver dysfunction influences blood product administration and alterations in circulating haemostatic markers following ventricular assist device implantation, Eur J Cardiothorac Surg, 47, 497, 10.1093/ejcts/ezu183
Lueck, 2016, Mechanical circulatory support for patients with peripartum cardiomyopathy, J Artif Organs, 19, 305, 10.1007/s10047-016-0891-z
Makdisi, 2017, Successful delivery in a patient with left ventricular assist device and unplanned pregnancy, Ann Thorac Surg, 104, e31, 10.1016/j.athoracsur.2017.01.071
Zimpfer, 2007, Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates, J Thorac Cardiovasc Surg, 133, 689, 10.1016/j.jtcvs.2006.08.104
Mikus, 2011, Reversibility of fixed pulmonary hypertension in left ventricular assist device support recipients, Eur J Cardiothorac Surg, 40, 971
Fendler, 2015, Incidence and predictors of cognitive decline in patients with left ventricular assist devices, Circ Cardiovasc Qual Outcomes, 8, 285, 10.1161/CIRCOUTCOMES.115.001856
Iodice, 2015, Implantation of a left ventricular assist device as a destination therapy in Duchenne muscular dystrophy patients with end stage cardiac failure: management and lessons learned, Neuromuscular Disord, 25, 19, 10.1016/j.nmd.2014.08.008
Cajita, 2017, Heart transplant centers with multidisciplinary team show a higher level of chronic illness management—findings from the International BRIGHT Study, Heart Lung, 46, 351, 10.1016/j.hrtlng.2017.05.006
Fried, 2014, Prior hematologic conditions carry a high morbidity and mortality in patients supported with continuous-flow left ventricular assist devices, J Heart Lung Transplant, 33, 1119, 10.1016/j.healun.2014.07.002
Schroder, 2007, Heparin-induced thrombocytopenia in left ventricular assist device bridge-to-transplant patients, Ann Thorac Surg, 84, 841, 10.1016/j.athoracsur.2007.03.049
Mountis, 2009, Management of left ventricular assist devices after surgery: bridge, destination, and recovery, Curr Opin Cardiol, 24, 252, 10.1097/HCO.0b013e32832c7c09
Starling, 2011, Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support), J Am Coll Cardiol, 57, 1890, 10.1016/j.jacc.2010.10.062
Pagani, 2009, Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device, J Am Coll Cardiol, 54, 312, 10.1016/j.jacc.2009.03.055
Miller, 2007, Use of a continuous-flow device in patients awaiting heart transplantation, N Engl J Med, 357, 885, 10.1056/NEJMoa067758
Aaronson, 2012, Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation, Circulation, 125, 3191, 10.1161/CIRCULATIONAHA.111.058412
Slaughter, 2013, HeartWare ventricular assist system for bridge to transplant: combined results of the bridge to transplant and continued access protocol trial, J Heart Lung Transplant, 32, 675, 10.1016/j.healun.2013.04.004
Strueber, 2011, Multicenter evaluation of an intrapericardial left ventricular assist system, J Am Coll Cardiol, 57, 1375, 10.1016/j.jacc.2010.10.040
Krabatsch, 2017, Heartmate 3 fully magnetically levitated left ventricular assist device for the treatment of advanced heart failure—1 year results from the CE mark trial, J Cardiothorac Surg, 12, 23., 10.1186/s13019-017-0587-3
Mehra, 2017, A fully magnetically levitated circulatory pump for advanced heart failure, N Engl J Med, 376, 440, 10.1056/NEJMoa1610426
Rogers, 2017, Intrapericardial left ventricular assist device for advanced heart failure, N Engl J Med, 376, 451, 10.1056/NEJMoa1602954
Slaughter, 2009, Advanced heart failure treated with continuous-flow left ventricular assist device, N Engl J Med, 361, 2241, 10.1056/NEJMoa0909938
Park, 2012, Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy, Circ Heart Fail, 5, 241, 10.1161/CIRCHEARTFAILURE.111.963991
Jorde, 2014, Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS Registry (Interagency Registry for Mechanically Assisted Circulatory Support), J Am Coll Cardiol, 63, 1751, 10.1016/j.jacc.2014.01.053
Gustafsson, 2018, Six-month outcomes after treatment of advanced heart failure with a full magnetically levitated continuous flow left ventricular assist device: report from the ELEVATE registry, Eur Heart J, 39, 3454, 10.1093/eurheartj/ehy513
Maltais, 2017, Left lateral thoracotomy for centrifugal continuous-flow left ventricular assist device placement: an analysis from the mechanical circulatory support research network, ASAIO J, 64, 715, 10.1097/MAT.0000000000000714
Sileshi, 2016, Outcomes of patients implanted using a left thoracotomy technique for a miniaturized centrifugal continuous-flow pump, ASAIO J, 62, 539, 10.1097/MAT.0000000000000407
Haberl, 2014, Viennese approach to minimize the invasiveness of ventricular assist device implantation, Eur J Cardiothorac Surg, 46, 991, 10.1093/ejcts/ezu051
Strueber, 2014, A minimally invasive off-pump implantation technique for continuous-flow left ventricular assist devices: early experience, J Heart Lung Transplant, 33, 851, 10.1016/j.healun.2014.05.016
Theiss, 2014, Preconditioning with levosimendan before implantation of left ventricular assist devices, Artif Organs, 38, 231, 10.1111/aor.12150
Sponga, 2012, Preoperative treatment with levosimendan in candidates for mechanical circulatory support, ASAIO J, 58, 6, 10.1097/MAT.0b013e318239f401
Dandel, 2013, Load dependency of right ventricular performance is a major factor to be considered in decision-making before ventricular assist device implantation, Circulation, 128, S14, 10.1161/CIRCULATIONAHA.112.000335
Kukucka, 2011, Acute impact of left ventricular unloading by left ventricular assist device on the right ventricle geometry and function: effect of nitric oxide inhalation, J Thorac Cardiovasc Surg, 141, 1009, 10.1016/j.jtcvs.2010.08.010
Potapov, 2008, Tricuspid incompetence and geometry of the right ventricle as predictors of right ventricular function after implantation of a left ventricular assist device, J Heart Lung Transplant, 27, 1275, 10.1016/j.healun.2008.08.012
Raina, 2013, Postoperative right ventricular failure after left ventricular assist device placement is predicted by preoperative echocardiographic structural, hemodynamic, and functional parameters, J Card Fail, 19, 16, 10.1016/j.cardfail.2012.11.001
Grant, 2012, Independent and incremental role of quantitative right ventricular evaluation for the prediction of right ventricular failure after left ventricular assist device implantation, J Am Coll Cardiol, 60, 521, 10.1016/j.jacc.2012.02.073
Dang, 2006, Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure, J Heart Lung Transplant, 25, 1, 10.1016/j.healun.2005.07.008
Matthews, 2008, The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates, J Am Coll Cardiol, 51, 2163, 10.1016/j.jacc.2008.03.009
Ochiai, 2002, Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients, Circulation, 106, I198, 10.1161/01.cir.0000032906.33237.1c
Shiga, 2012, Combination evaluation of preoperative risk indices predicts requirement of biventricular assist device, Circ J, 76, 2785, 10.1253/circj.CJ-12-0231
Cleveland, 2011, Survival after biventricular assist device implantation: an analysis of the Interagency Registry for Mechanically Assisted Circulatory Support database, J Heart Lung Transplant, 30, 862
Takeda, 2013, Timing of temporary right ventricular assist device insertion for severe right heart failure after left ventricular assist device implantation, ASAIO J, 59, 564, 10.1097/MAT.0b013e3182a816d1
Lazar, 2013, Survival after left ventricular assist device with and without temporary right ventricular support, Ann Thorac Surg, 96, 2155, 10.1016/j.athoracsur.2013.07.008
Fitzpatrick, 2009, Early planned institution of biventricular mechanical circulatory support results in improved outcomes compared with delayed conversion of a left ventricular assist device to a biventricular assist device, J Thorac Cardiovasc Surg, 137, 971, 10.1016/j.jtcvs.2008.09.021
Aissaoui, 2014, Comparison of biventricular and left ventricular assist devices for the management of severe right ventricular dysfunction in patients with end-stage heart failure, ASAIO J, 60, 400, 10.1097/MAT.0000000000000082
Morgan, 2004, Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant mortality, Ann Thorac Surg, 77, 859, 10.1016/j.athoracsur.2003.09.048
Grimm, 2016, Outcomes in patients bridged with univentricular and biventricular devices in the modern era of heart transplantation, Ann Thorac Surg, 102, 102, 10.1016/j.athoracsur.2016.01.019
Levin, 2016, Outcomes of contemporary mechanical circulatory support device configurations in patients with severe biventricular failure, J Thorac Cardiovasc Surg, 151, 530, 10.1016/j.jtcvs.2015.10.019
Maeder, 2009, Changes in right ventricular function during continuous-flow left ventricular assist device support [corrected], J Heart Lung Transplant, 28, 360, 10.1016/j.healun.2009.01.007
Drakos, 2010, Risk factors predictive of right ventricular failure after left ventricular assist device implantation, Am J Cardiol, 105, 1030, 10.1016/j.amjcard.2009.11.026
Kirklin, 2013, Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients, J Heart Lung Transplant, 32, 141, 10.1016/j.healun.2012.12.004
Kormos, 2010, Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes, J Thorac Cardiovasc Surg, 139, 1316, 10.1016/j.jtcvs.2009.11.020
Noly, 2014, Temporary right ventricular support following left ventricle assist device implantation: a comparison of two techniques, Interact CardioVasc Thorac Surg, 19, 49, 10.1093/icvts/ivu072
Takeda, 2014, Outcome of unplanned right ventricular assist device support for severe right heart failure after implantable left ventricular assist device insertion, J Heart Lung Transplant, 33, 141, 10.1016/j.healun.2013.06.025
Loforte, 2010, Simultaneous temporary CentriMag right ventricular assist device placement in HeartMate II left ventricular assist system recipients at high risk of right ventricular failure, Interact CardioVasc Thorac Surg, 10, 847, 10.1510/icvts.2009.230706
Takayama, 2012, A novel approach to percutaneous right-ventricular mechanical support, Eur J Cardiothorac Surg, 41, 423, 10.1016/j.ejcts.2011.05.041
Schmack, 2016, Concurrent left ventricular assist device (LVAD) implantation and percutaneous temporary RVAD support via CardiacAssist Protek-Duo TandemHeart to preempt right heart failure, Med Sci Monit Basic Res, 22, 53, 10.12659/MSMBR.898897
Schaefer, 2017, Outcomes of minimally invasive temporary right ventricular assist device support for acute right ventricular failure during minimally invasive left ventricular assist device implantation, ASAIO J, 63, 546, 10.1097/MAT.0000000000000526
Saeed, 2015, Alternative right ventricular assist device implantation technique for patients with perioperative right ventricular failure, J Thorac Cardiovasc Surg, 149, 927, 10.1016/j.jtcvs.2014.10.104
Saito, 2012, Recovery of right heart function with temporary right ventricular assist using a centrifugal pump in patients with severe biventricular failure, J Heart Lung Transplant, 31, 858, 10.1016/j.healun.2012.03.002
Loforte, 2013, Temporary right ventricular mechanical support in high-risk left ventricular assist device recipients versus permanent biventricular or total artificial heart support, Artif Organs, 37, 523, 10.1111/aor.12038
Cheng, 2016, Comparison of total artificial heart and biventricular assist device support as bridge-to-transplantation, J Card Surg, 31, 648, 10.1111/jocs.12823
Schmack, 2018, Successful support of biventricular heart failure patients by new EXCOR® Adult pumps with bileaflet valves: a prospective study, Clin Res Cardiol, 107, 413, 10.1007/s00392-017-1200-4
Tsukui, 2005, Biventricular assist device utilization for patients with morbid congestive heart failure: a justifiable strategy, Circulation, 112, I65, 10.1161/CIRCULATIONAHA.104.524934
Slaughter, 2007, Results of a multicenter clinical trial with the thoratec implantable ventricular assist device, J Thorac Cardiovasc Surg, 133, 1573, 10.1016/j.jtcvs.2006.11.050
Holman, 2009, Predictors of death and transplant in patients with a mechanical circulatory support device: a multi-institutional study, J Heart Lung Transplant, 28, 44, 10.1016/j.healun.2008.10.011
Arabia, 2017, Biventricular support with intracorporeal, continuous flow, centrifugal ventricular assist devices, Ann Thorac Surg, 105, 548, 10.1016/j.athoracsur.2017.08.019
Kirsch, 2012, Survival after biventricular mechanical circulatory support: does the type of device matter?, J Heart Lung Transplant, 31, 501, 10.1016/j.healun.2011.11.024
Potapov, 2012, Discontinuation of HeartWare RVAD support without device removal in chronic BIVAD patients, ASAIO J, 58, 15, 10.1097/MAT.0b013e3182376b7b
Tran, 2017, Durable biventricular support using right atrial placement of the HeartWare HVAD, ASAIO J, 64, 323, 10.1097/MAT.0000000000000645
Krabatsch, 2011, Biventricular circulatory support with two miniaturized implantable assist devices, Circulation, 124, S179, 10.1161/CIRCULATIONAHA.110.011502
Torregrossa, 2014, Results with SynCardia total artificial heart beyond 1 year, ASAIO J, 60, 626, 10.1097/MAT.0000000000000132
Thanavaro, 2014, Clinical indications for implantation of the total artificial heart, ASAIO J, 60, 594, 10.1097/MAT.0000000000000111
Copeland, 2012, Experience with more than 100 total artificial heart implants, J Thorac Cardiovasc Surg, 143, 727, 10.1016/j.jtcvs.2011.12.002
Nguyen, 2015, Bridge to transplantation using paracorporeal biventricular assist devices or the syncardia temporary total artificial heart: is there a difference?, J Cardiovasc Surg (Torino), 56, 493
Kirsch, 2013, SynCardia temporary total artificial heart as bridge to transplantation: current results at la pitie hospital, Ann Thorac Surg, 95, 1640, 10.1016/j.athoracsur.2013.02.036
Carpentier, 2015, First clinical use of a bioprosthetic total artificial heart: report of two cases, Lancet, 386, 1556, 10.1016/S0140-6736(15)60511-6
Kremer, 2016, Total artificial heart implantation after undifferentiated high-grade sarcoma excision, Med Sci Monit Basic Res, 22, 128, 10.12659/MSMBR.901526
Reich, 2015, Total artificial heart bridge to transplantation for a patient with occult intracardiac malignancy: case report, Transplant Proc, 47, 2291, 10.1016/j.transproceed.2015.04.083
Ried, 2010, Sequential therapy of primary cardiac lymphoma with cardiectomy, total artificial heart support, and cardiac transplantation, J Heart Lung Transplant, 29, 707, 10.1016/j.healun.2010.01.014
Strueber, 2012, Placement of 2 implantable centrifugal pumps to serve as a total artificial heart after cardiectomy, J Thorac Cardiovasc Surg, 143, 507, 10.1016/j.jtcvs.2011.07.034
Knezevic, 2013, Use of a totally artificial heart for a complex postinfarction ventricular septal defect, Heart Surg Forum, 16, 155, 10.1532/HSF98.20121142
Ashfaq, 2013, The role of the total artificial heart in the treatment of post-myocardial infarction ventricular septal defect, J Thorac Cardiovasc Surg, 145, e25, 10.1016/j.jtcvs.2012.11.018
Morales, 2012, Implantation of total artificial heart in congenital heart disease, Semin Thorac Cardiovasc Surg, 24, 142, 10.1053/j.semtcvs.2012.04.006
Rossano, 2014, Successful use of the total artificial heart in the failing Fontan circulation, Ann Thorac Surg, 97, 1438, 10.1016/j.athoracsur.2013.06.120
Copeland, 2013, Results with an anticoagulation protocol in 99 SynCardia total artificial heart recipients, ASAIO J, 59, 216, 10.1097/MAT.0b013e318288a390
Lavee, 2018, An international multicenter experience of biventricular support with HeartMate 3 ventricular assist systems, J Heart Lung Transplant, 37, 1399, 10.1016/j.healun.2018.08.008
Eulert-Grehn, 2018, Two implantable continuous-flow ventricular assist devices in a biventricular configuration: technique and results, Interact CardioVasc Thorac Surg, 27, 938, 10.1093/icvts/ivy228
Broussard, 2011, Anesthesia for left ventricular assist device insertion: a case series and review, Ochsner J, 11, 70
Kocabas, 2013, Anesthesia for ventricular assist device placement: experience from a single center, Transplant Proc, 45, 1005, 10.1016/j.transproceed.2013.02.091
Sanjay, 2016, Perioperative management of left ventricular assist devices, Ann Card Anaesth, 19, S19, 10.4103/0971-9784.192604
Hind, 2003, Ultrasonic locating devices for central venous cannulation: meta-analysis, BMJ, 327, 361., 10.1136/bmj.327.7411.361
Long, 2006, Effect of heparin-bonded central venous catheters on the incidence of catheter-related thrombosis and infection in children and adults, Anaesth Intensive Care, 34, 481., 10.1177/0310057X0603400418
Palepu, 2009, Impact of ultrasonography on central venous catheter insertion in intensive care, Indian J Radiol Imaging, 19, 191, 10.4103/0971-3026.54877
Calvert, 2003, The effectiveness and cost-effectiveness of ultrasound locating devices for central venous access: a systematic review and economic evaluation, Health Technol Assess, 7, 1, 10.3310/hta7120
Schwann, 2011, Lack of effectiveness of the pulmonary artery catheter in cardiac surgery, Anesth Analg, 113, 994, 10.1213/ANE.0b013e31822c94a8
Cowie, 2011, Does the pulmonary artery catheter still have a role in the perioperative period?, Anaesth Intensive Care, 39, 345, 10.1177/0310057X1103900305
Kanchi, 2011, Do we need a pulmonary artery catheter in cardiac anesthesia?—An Indian perspective, Ann Card Anaesth, 14, 25, 10.4103/0971-9784.74396
El-Magharbel, 2005, Ventricular assist devices and anesthesia, Semin Cardiothorac Vasc Anesth, 9, 241, 10.1177/108925320500900306
Myles, 2004, Bispectral index monitoring to prevent awareness during anaesthesia: the B-Aware randomised controlled trial, Lancet, 363, 1757, 10.1016/S0140-6736(04)16300-9
Schon, 2011, Relationship between mixed venous oxygen saturation and regional cerebral oxygenation in awake, spontaneously breathing cardiac surgery patients, Minerva Anestesiol, 77, 952
Morel, 2011, Haemodynamic consequences of etomidate administration in elective cardiac surgery: a randomized double-blinded study, Br J Anaesth, 107, 503, 10.1093/bja/aer169
Aviado, 1957, Effects of anoxia on pulmonary circulation: reflex pulmonary vasoconstriction, Am J Physiol, 189, 253, 10.1152/ajplegacy.1957.189.2.253
Walkey, 2017, Low tidal volume versus non-volume-limited strategies for patients with acute respiratory distress syndrome: a systematic review and meta-analysis, Ann Am Thorac Soc, 14, S271, 10.1513/AnnalsATS.201704-337OT
Chumnanvej, 2007, Perioperative echocardiographic examination for ventricular assist device implantation, Anesth Analg, 105, 583, 10.1213/01.ane.0000278088.22952.82
Scalia, 2000, Clinical utility of echocardiography in the management of implantable ventricular assist devices, J Am Soc Echocardiogr, 13, 754, 10.1067/mje.2000.105009
Lang, 2015, Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging, Eur Heart J Cardiovasc Imaging, 16, 233, 10.1093/ehjci/jev014
Nicoara, 2007, Malpositioned left ventricular assist device cannula: diagnosis and management with transesophageal echocardiography guidance, Anesth Analg, 105, 1574, 10.1213/01.ane.0000286065.39763.bc
Pieri, 2017, Heart failure after 5 years on LVAD: diagnosis and treatment of outflow graft obstruction, ASAIO J, 63, e1, 10.1097/MAT.0000000000000370
Wagner, 1997, Nitric oxide inhalation in the treatment of right ventricular dysfunction following left ventricular assist device implantation, Circulation, 96, II-291
Argenziano, 1998, Randomized, double-blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension, Ann Thorac Surg, 65, 340, 10.1016/S0003-4975(97)01307-6
Potapov, 2011, Inhaled nitric oxide after left ventricular assist device implantation: a prospective, randomized, double-blind, multicenter, placebo-controlled trial, J Heart Lung Transplant, 30, 870
Benedetto, 2015, Inhaled nitric oxide in cardiac surgery: evidence or tradition?, Nitric Oxide, 49, 67, 10.1016/j.niox.2015.06.002
Peura, 2012, Recommendations for the use of mechanical circulatory support: device strategies and patient selection: a scientific statement from the American Heart Association, Circulation, 126, 2648, 10.1161/CIR.0b013e3182769a54
Bolliger, 2013, Roles of thrombelastography and thromboelastometry for patient blood management in cardiac surgery, Transfus Med Rev, 27, 213, 10.1016/j.tmrv.2013.08.004
Wikkelsoe, 2011, Monitoring patients at risk of massive transfusion with thrombelastography or thromboelastometry: a systematic review, Acta Anaesthesiol Scand, 55, 1174, 10.1111/j.1399-6576.2011.02534.x
Deppe, 2016, Point-of-care thromboelastography/thromboelastometry-based coagulation management in cardiac surgery: a meta-analysis of 8332 patients, J Surg Res, 203, 424, 10.1016/j.jss.2016.03.008
Heringlake, 2011, Preoperative cerebral oxygen saturation and clinical outcomes in cardiac surgery, Anesthesiology, 114, 58, 10.1097/ALN.0b013e3181fef34e
Haglund, 2015, Inhaled milrinone after left ventricular assist device implantation, J Card Fail, 21, 792, 10.1016/j.cardfail.2015.04.011
Klodell, 2007, Effect of sildenafil on pulmonary artery pressure, systemic pressure, and nitric oxide utilization in patients with left ventricular assist devices, Ann Thorac Surg, 83, 68, 10.1016/j.athoracsur.2006.08.051
Trachte, 2005, Oral sildenafil reduces pulmonary hypertension after cardiac surgery, Ann Thorac Surg, 79, 194, 10.1016/j.athoracsur.2004.06.086
Netuka, 2015, Fully magnetically levitated left ventricular assist system for treating advanced HF: a multicenter study, J Am Coll Cardiol, 66, 2579, 10.1016/j.jacc.2015.09.083
Cheng, 2017, Device strategies for patients in INTERMACS profiles 1 and 2 cardiogenic shock: double bridge with extracorporeal membrane oxygenation and initial implant of more durable devices, Artif Organs, 41, 224, 10.1111/aor.12758
Frazier, 2006, Initial experience with non-thoracic, extraperitoneal, off-pump insertion of the Jarvik 2000 Heart in patients with previous median sternotomy, J Heart Lung Transplant, 25, 499, 10.1016/j.healun.2005.12.003
Potapov, 2017, Off-pump implantation of the HeartMate 3 left ventricular assist device through a bilateral thoracotomy approach, J Thorac Cardiovasc Surg, 153, 104, 10.1016/j.jtcvs.2016.09.028
Hanke, 2017, In vitro evaluation of inflow cannula fixation techniques in left ventricular assist device surgery, Artif Organs, 41, 272, 10.1111/aor.12735
Hanke, 2015, Minimally-invasive LVAD Implantation: state of the Art, Curr Cardiol Rev, 11, 246, 10.2174/1573403X1103150514151750
Muthiah, 2013, Centrifugal continuous-flow left ventricular assist device in patients with hypertrophic cardiomyopathy: a case series, ASAIO J, 59, 183, 10.1097/MAT.0b013e318286018d
Deo, 2013, Centrifugal continuous-flow left ventricular assist device in patients with hypertrophic cardiomyopathy: a case series, ASAIO J, 59, 97, 10.1097/MAT.0b013e318285ca8d
Hanke, 2017, First results of HeartWare left ventricular assist device implantation with tunnelling of the outflow graft through the transverse sinus, Interact CardioVasc Thorac Surg, 25, 503, 10.1093/icvts/ivx124
Nawata, 2010, Outcomes of midterm circulatory support by left ventricular assist device implantation with descending aortic anastomosis, J Artif Organs, 13, 197, 10.1007/s10047-010-0521-0
Zucchetta, 2014, The Jarvik-2000 ventricular assist device implantation: how we do it, Ann Cardiothorac Surg, 3, 525
Hanke, 2015, Minimally invasive left ventricular assist device implantation with outflow graft anastomosis to the innominate artery, J Thorac Cardiovasc Surg, 149, e69, 10.1016/j.jtcvs.2014.12.066
Dean, 2015, Reduction in driveline infection rates: results from the HeartMate II Multicenter Driveline Silicone Skin Interface (SSI) Registry, J Heart Lung Transplant, 34, 781, 10.1016/j.healun.2014.11.021
Schibilsky, 2012, Double tunnel technique for the LVAD driveline: improved management regarding driveline infections, J Artif Organs, 15, 44, 10.1007/s10047-011-0607-3
Svenarud, 2004, Effect of CO2 insufflation on the number and behavior of air microemboli in open-heart surgery: a randomized clinical trial, Circulation, 109, 1127, 10.1161/01.CIR.0000118501.44474.83
Martens, 2001, Conventional carbon dioxide application does not reduce cerebral or myocardial damage in open heart surgery, Ann Thorac Surg, 72, 1940, 10.1016/S0003-4975(01)03224-6
Schmitto, 2014, Minimally invasive left ventricular assist device explantation after cardiac recovery: surgical technical considerations, Artif Organs, 38, 507, 10.1111/aor.12201
Stulak, 2012, Delayed sternal closure does not increase late infection risk in patients undergoing left ventricular assist device implantation, J Heart Lung Transplant, 31, 1115, 10.1016/j.healun.2012.08.015
Bhama, 2018, Clinical experience with temporary right ventricular mechanical circulatory support, J Thorac Cardiovasc Surg, 156, 1885, 10.1016/j.jtcvs.2018.04.094
Potapov, 2016, Biventricular support using 2 HeartMate 3 pumps, J Heart Lung Transplant, 35, 1268, 10.1016/j.healun.2016.07.013
Potapov, 2010, A titanium plug simplifies left ventricular assist device removal after myocardial recovery, J Heart Lung Transplant, 29, 1316, 10.1016/j.healun.2010.06.008
Dykes, 2017, Alternative strategy for biventricular assist device in an infant with hypertrophic cardiomyopathy, Ann Thorac Surg, 104, e185, 10.1016/j.athoracsur.2017.02.069
Loebe, 2011, Initial clinical experience of total cardiac replacement with dual HeartMate-II axial flow pumps for severe biventricular heart failure, Methodist Debakey Cardiovasc J, 7, 40, 10.14797/mdcj-7-1-40
Pirk, 2013, Total artificial heart support with two continuous-flow ventricular assist devices in a patient with an infiltrating cardiac sarcoma, ASAIO J, 59, 178, 10.1097/MAT.0b013e3182816cd9
Haj-Yahia, 2008, Limited surgical approach for explanting the HeartMate II left ventricular assist device after myocardial recovery, J Thorac Cardiovasc Surg, 135, 453, 10.1016/j.jtcvs.2007.10.012
Cohn, 2007, A felt plug simplifies left ventricular assist device removal after successful bridge to recovery, J Heart Lung Transplant, 26, 1209, 10.1016/j.healun.2007.07.029
Pettit, 2015, Percutaneous withdrawal of HeartWare HVAD left ventricular assist device support, J Heart Lung Transplant, 34, 990, 10.1016/j.healun.2015.02.002
Choi, 2018, Left ventricular assist device decommissioning compared with explantation for ventricular recovery: a systematic review, ASAIO J, 1, 10.1097/MAT.0000000000000926
VanderPluym, 2017, Outcomes following implantation of mechanical circulatory support in adults with congenital heart disease: an analysis of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS), J Heart Lung Transplant, 37, 89, 10.1016/j.healun.2017.03.005
de By, 2018, The European Registry for Patients with Mechanical Circulatory Support (EUROMACS): first EUROMACS Paediatric (Paedi-EUROMACS) report, Eur J Cardiothorac Surg, 54, 800, 10.1093/ejcts/ezy298
Schweiger, 2017, Cerebral strokes in children on intracorporeal ventricular assist devices: analysis of the EUROMACS Registry, Eur J Cardiothorac Surg, 53, 416, 10.1093/ejcts/ezx342
Villa, 2017, United States trends in pediatric ventricular assist implantation as bridge to transplantation, ASAIO J, 63, 470, 10.1097/MAT.0000000000000524
Rossano, 2016, Outcomes of pediatric patients supported with continuous-flow ventricular assist devices: a report from the Pediatric Interagency Registry for Mechanical Circulatory Support (PediMACS), J Heart Lung Transplant, 35, 585, 10.1016/j.healun.2016.01.1228
Miera, 2011, First experiences with the HeartWare ventricular assist system in children, Ann Thorac Surg, 91, 1256, 10.1016/j.athoracsur.2010.12.013
Miera, 2016, A multicenter study of the HeartWare ventricular assist device in small children, J Heart Lung Transplant, 35, 679, 10.1016/j.healun.2016.01.019
Chen, 2016, Outpatient outcomes of pediatric patients with left ventricular assist devices, ASAIO J, 62, 163, 10.1097/MAT.0000000000000324
Adachi, 2016, Mechanically assisted Fontan completion: a new approach for the failing Glenn circulation due to isolated ventricular dysfunction, J Heart Lung Transplant, 35, 1380, 10.1016/j.healun.2016.09.011
Schweiger, 2015, Outpatient management of intra-corporeal left ventricular assist device system in children: a multi-center experience, Am J Transplant, 15, 453, 10.1111/ajt.13003
Conway, 2016, Global experience with the HeartWare HVAD® in pediatric patients: a preliminary analysis, J Heart Lung Transplant, 35, 1., 10.1016/j.healun.2016.01.121
Lowry, 2012, The potential to avoid heart transplantation in children: outpatient bridge to recovery with an intracorporeal continuous-flow left ventricular assist device in a 14-year-old, Congenit Heart Dis, 7, E91., 10.1111/j.1747-0803.2012.00659.x
Conway, 2015, Delineating survival outcomes in children <10 kg bridged to transplant or recovery with the Berlin Heart EXCOR ventricular assist device, JACC Heart Fail, 3, 70, 10.1016/j.jchf.2014.07.011
Morales, 2017, Berlin Heart EXCOR use in patients with congenital heart disease, J Heart Lung Transplant, 36, 1209, 10.1016/j.healun.2017.02.003
Cabrera, 2013, Outcomes of pediatric patients supported by the HeartMate II left ventricular assist device in the United States, J Heart Lung Transplant, 32, 1107, 10.1016/j.healun.2013.07.012
Blume, 2016, Outcomes of children implanted with ventricular assist devices in the United States: first analysis of the Pediatric Interagency Registry for Mechanical Circulatory Support (PediMACS), J Heart Lung Transplant, 35, 578, 10.1016/j.healun.2016.01.1227
Poh, 2017, Ventricular assist device support in patients with single ventricles: the Melbourne experience, Interact CardioVasc Thorac Surg, 25, 310, 10.1093/icvts/ivx066
Weinstein, 2014, The use of the Berlin heart EXCOR in patients with functional single ventricle, J Thorac Cardiovasc Surg, 147, 697, 10.1016/j.jtcvs.2013.10.030
Irving, 2009, Successful bridge to transplant with the berlin heart after cavopulmonary shunt, J Heart Lung Transplant, 28, 399, 10.1016/j.healun.2008.12.009
Throckmorton, 2013, A viable therapeutic option: mechanical circulatory support of the failing Fontan physiology, Pediatr Cardiol, 34, 1357, 10.1007/s00246-013-0649-9
Giridharan, 2013, Performance evaluation of a pediatric viscous impeller pump for Fontan cavopulmonary assist, J Thorac Cardiovasc Surg, 145, 249, 10.1016/j.jtcvs.2012.01.082
Haggerty, 2012, Experimental and numeric investigation of Impella pumps as cavopulmonary assistance for a failing Fontan, J Thorac Cardiovasc Surg, 144, 563, 10.1016/j.jtcvs.2011.12.063
Pretre, 2008, Right-sided univentricular cardiac assistance in a failing Fontan circulation, Ann Thorac Surg, 86, 1018, 10.1016/j.athoracsur.2008.03.003
Rodefeld, 2010, Cavopulmonary assist for the univentricular Fontan circulation: von Karman viscous impeller pump, J Thorac Cardiovasc Surg, 140, 529, 10.1016/j.jtcvs.2010.04.037
Pace Napoleone, 2017, Ventricular assist device in a failing total cavopulmonary connection: a new step-by-step approach, Interact CardioVasc Thorac Surg, 26, 341, 10.1093/icvts/ivx288
Wells, 2017, The 50/50 cc total artificial heart trial: extending the benefits of the total artificial heart to underserved populations, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, 20, 16, 10.1053/j.pcsu.2016.09.004
Morales, 2017, Worldwide experience with the SynCardia total artificial heart in the pediatric population, ASAIO J, 63, 518, 10.1097/MAT.0000000000000504
Steiner, 2017, Durable mechanical circulatory support in teenagers and adults with congenital heart disease: a systematic review, Int J Cardiol, 245, 135, 10.1016/j.ijcard.2017.07.107
Stokes, 2016, Successful bridge to orthotopic cardiac transplantation with implantation of a HeartWare HVAD in management of systemic right ventricular failure in a patient with transposition of the great arteries and previous atrial switch procedure, Heart Lung Circ, 25, e69, 10.1016/j.hlc.2015.11.006
Tanoue, 2016, Jarvik 2000 axial-flow ventricular assist device placement to a systemic morphologic right ventricle in congenitally corrected transposition of the great arteries, J Artif Organs, 19, 97, 10.1007/s10047-015-0866-5
Maly, 2015, Bridge to transplantation with long-term mechanical assist device in adults after the Mustard procedure, J Heart Lung Transplant, 34, 1177, 10.1016/j.healun.2015.03.025
Dakkak, 2015, Implanting a nonpulsatile axial flow left ventricular assist device as a bridge to transplant for systemic ventricular failure after a mustard procedure, Exp Clin Transplant, 13, 485
Schweiger, 2015, Biventricular failure in dextro-transposition of the great arteries corrected with the Mustard procedure: VAD support of the systemic ventricle is enough, Int J Artif Organs, 38, 233, 10.5301/ijao.5000400
Fraser, 2012, Prospective trial of a pediatric ventricular assist device, N Engl J Med, 367, 532, 10.1056/NEJMoa1014164
Morales, 2011, Bridging children of all sizes to cardiac transplantation: the initial multicenter North American experience with the Berlin Heart EXCOR ventricular assist device, J Heart Lung Transplant, 30, 1, 10.1016/j.healun.2010.08.033
Almond, 2013, Berlin Heart EXCOR pediatric ventricular assist device for bridge to heart transplantation in US children, Circulation, 127, 1702, 10.1161/CIRCULATIONAHA.112.000685
Zafar, 2017, Does small size matter with continuous flow devices? Analysis of the INTERMACS database of adults with BSA </=1.5 m2, JACC Heart Fail, 5, 123, 10.1016/j.jchf.2016.09.009
Ferng, 2017, Translation of first North American 50 and 70 cc total artificial heart virtual and clinical implantations: utility of 3D computed tomography to test fit devices, Artif Organs, 41, 727, 10.1111/aor.12854
Moore, 2016, Virtual implantation of the 50cc SynCardia total artificial heart, J Heart Lung Transplant, 35, 824, 10.1016/j.healun.2015.12.026
Moore, 2014, Virtual implantation evaluation of the total artificial heart and compatibility: beyond standard fit criteria, J Heart Lung Transplant, 33, 1180, 10.1016/j.healun.2014.08.010
Maxwell, 2014, Heart transplantation with or without prior mechanical circulatory support in adults with congenital heart disease, Eur J Cardiothorac Surg, 45, 842, 10.1093/ejcts/ezt498
Gelow, 2013, Organ allocation in adults with congenital heart disease listed for heart transplant: impact of ventricular assist devices, J Heart Lung Transplant, 32, 1059, 10.1016/j.healun.2013.06.024
Maltais, 2013, Episodic monoplane transesophageal echocardiography impacts postoperative management of the cardiac surgery patient, J Cardiothorac Vasc Anesth, 27, 665, 10.1053/j.jvca.2013.02.012
Ranucci, 2006, Which cardiac surgical patients can benefit from placement of a pulmonary artery catheter?, Crit Care, 10, S6., 10.1186/cc4833
Geisen, 2014, Echocardiography-based hemodynamic management in the cardiac surgical intensive care unit, J Cardiothorac Vasc Anesth, 28, 733, 10.1053/j.jvca.2013.08.006
Kato, 2013, Serial echocardiography using tissue Doppler and speckle tracking imaging to monitor right ventricular failure before and after left ventricular assist device surgery, JACC Heart Fail, 1, 216, 10.1016/j.jchf.2013.02.005
Riebandt, 2017, Extracorporeal membrane oxygenation support for right ventricular failure after left ventricular assist device implantation; temporary right ventricular support following left ventricle assist device implantation: a comparison of two techniques, Eur J Cardiothorac Surg, 19, 49
Takeda, 2017, Improved outcomes from extracorporeal membrane oxygenation versus ventricular assist device temporary support of primary graft dysfunction in heart transplant, J Heart Lung Transplant, 36, 650, 10.1016/j.healun.2016.12.006
Antoniou, 2012, Inhaled nitric oxide plus iloprost in the setting of post-left assist device right heart dysfunction, Ann Thorac Surg, 94, 792, 10.1016/j.athoracsur.2012.04.046
Groves, 2014, Effects of early inhaled epoprostenol therapy on pulmonary artery pressure and blood loss during LVAD placement, J Cardiothorac Vasc Anesth, 28, 652, 10.1053/j.jvca.2013.05.028
Hamdan, 2014, Prevention of right heart failure after left ventricular assist device implantation by phosphodiesterase 5 inhibitor, Artif Organs, 38, 963, 10.1111/aor.12277
Lovich, 2015, Inhaled nitric oxide augments left ventricular assist device capacity by ameliorating secondary right ventricular failure, ASAIO J, 61, 379, 10.1097/MAT.0000000000000211
Sabato, 2017, Inhaled pulmonary vasodilator therapy for management of right ventricular dysfunction after left ventricular assist device placement and cardiac transplantation. Clinical outcomes of patients treated with pulmonary vasodilators early and in high dose after left ventricular assist device implantation, Pharmacotherapy, 37, 944, 10.1002/phar.1959
De Backer, 2010, Comparison of dopamine and norepinephrine in the treatment of shock, N Engl J Med, 362, 779, 10.1056/NEJMoa0907118
Havel, 2011, Vasopressors for hypotensive shock, Cochrane Database Syst Rev, 10.1002/14651858.CD003709.pub3
Levy, 2011, Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study, Crit Care Med, 39, 450, 10.1097/CCM.0b013e3181ffe0eb
Tarvasmaki, 2016, Current real-life use of vasopressors and inotropes in cardiogenic shock - adrenaline use is associated with excess organ injury and mortality, Crit Care (London, England), 20, 208., 10.1186/s13054-016-1387-1
Burkhardt, 2015, Prophylactic milrinone for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart disease, Cochrane Database Syst Rev, 10.1002/14651858.CD009515.pub2
You, 2016, Effect of milrinone on cardiac functions in patients undergoing coronary artery bypass graft: a meta-analysis of randomized clinical trials, Drug Des Devel Ther, 10, 53
Landoni, 2017, Levosimendan for hemodynamic support after cardiac surgery, N Engl J Med, 376, 2021, 10.1056/NEJMoa1616325
Mehta, 2017, Levosimendan in patients with left ventricular dysfunction undergoing cardiac surgery, N Engl J Med, 376, 2032, 10.1056/NEJMoa1616218
Repesse, 2013, Recombinant factor VIIa for uncontrollable bleeding in patients with extracorporeal membrane oxygenation: report on 15 cases and literature review, Crit Care, 17, R55., 10.1186/cc12581
Gandhi, 2007, Use of activated recombinant factor VII for severe coagulopathy post ventricular assist device or orthotopic heart transplant, J Cardiothorac Surg, 2, 32., 10.1186/1749-8090-2-32
Slaughter, 2010, Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy, J Heart Lung Transplant, 29, 616, 10.1016/j.healun.2010.02.003
Joshi, 2008, Anticoagulant monitoring in ventricular assist device patients: a feasibility study, Interact CardioVasc Thorac Surg, 7, 1035, 10.1510/icvts.2008.186742
Bishop, 2014, Pharmacist-managed international normalized ratio patient self-testing is associated with increased time in therapeutic range in patients with left ventricular assist devices at an academic medical center, ASAIO J, 60, 193, 10.1097/MAT.0000000000000047
Sandner, 2014, Low-molecular-weight heparin for anti-coagulation after left ventricular assist device implantation, J Heart Lung Transplant, 33, 88, 10.1016/j.healun.2013.10.009
Andreas, 2017, Increased thromboembolic events with dabigatran compared with vitamin K antagonism in left ventricular assist device patients: a randomized controlled pilot trial, Circ Heart Fail, 10, 1
Pereira, 2010, Discontinuation of antithrombotic therapy for a year or more in patients with continuous-flow left ventricular assist devices, Interact CardioVasc Thorac Surg, 11, 503, 10.1510/icvts.2010.240747
Axelrad, 2018, Limited usefulness of endoscopic evaluation in patients with continuous-flow left ventricular assist devices and gastrointestinal bleeding, J Heart Lung Transplant, 37, 723, 10.1016/j.healun.2017.12.017
Ben Gal, 2015, Exercise programs for LVAD supported patients: a snapshot from the ESC affiliated countries, Int J Cardiol, 201, 215, 10.1016/j.ijcard.2015.08.081
Piepoli, 2011, Exercise training in heart failure: from theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation, Eur J Heart Fail, 13, 347, 10.1093/eurjhf/hfr017
Hayes, 2012, Effects of exercise training on exercise capacity and quality of life in patients with a left ventricular assist device: a preliminary randomized controlled trial, J Heart Lung Transplant, 31, 729, 10.1016/j.healun.2012.02.021
Marko, 2015, Safety and efficacy of cardiac rehabilitation for patients with continuous flow left ventricular assist devices, Eur J Prev Cardiol, 22, 1378, 10.1177/2047487314558772
Borg, 1982, Psychophysical bases of perceived exertion, Med Sci Sports Exerc, 14, 377, 10.1249/00005768-198205000-00012
Carvalho, 2011, Aerobic exercise training intensity in patients with chronic heart failure: principles of assessment and prescription, Eur J Cardiovasc Prev Rehabil, 18, 5, 10.1097/HJR.0b013e32833a9c63
Marko, 2017, Exercise performance during the first two years after left ventricular assist device implantation, ASAIO J, 63, 408, 10.1097/MAT.0000000000000569
Vanhees, 2012, Importance of characteristics and modalities of physical activity and exercise in the management of cardiovascular health in individuals with cardiovascular disease (part III), Eur J Prev Cardiol, 19, 1333, 10.1177/2047487312437063
Alsara, 2014, Is exercise training safe and beneficial in patients receiving left ventricular assist device therapy?, J Cardiopulm Rehabil Prev, 34, 233, 10.1097/HCR.0000000000000050
Pamboukian, 2011, Improvement in 2-year survival for ventricular assist device patients after implementation of an intensive surveillance protocol, J Heart Lung Transplant, 30, 879
Biefer, 2014, Experience with a “hotline” service for outpatients on a ventricular assist device, Thorac Cardiovasc Surg, 62, 409
Vierecke, 2017, Emergency procedures for patients with a continuous flow left ventricular assist device, Emerg Med J, 34, 831, 10.1136/emermed-2015-204912
Haglund, 2015, Readmissions after continuous flow left ventricular assist device implantation: differences observed between two contemporary device types, ASAIO J, 61, 410, 10.1097/MAT.0000000000000218
Chorpenning, 2014, HeartWare controller logs a diagnostic tool and clinical management aid for the HVAD pump, ASAIO J, 60, 115, 10.1097/MAT.0000000000000022
Lampert, 2015, Remote hemodynamic monitoring for ambulatory left ventricular assist device patients, J Thorac Dis, 7, 2165
Pektok, 2013, Remote monitoring of left ventricular assist device parameters after HeartAssist-5 implantation, Artif Organs, 37, 820, 10.1111/aor.12144
Noon, 2010, Current status of the MicroMed DeBakey noon ventricular assist device, Tex Heart Inst J, 37, 652
Schmitto, 2017, First implantation of a novel left ventricular assist device: the ReliantHeart aVAD, Ann Thorac Surg, 104, e311, 10.1016/j.athoracsur.2017.04.049
Hannan, 2011, Working formulation for the standardization of definitions of infections in patients using ventricular assist devices, J Heart Lung Transplant, 30, 375, 10.1016/j.healun.2011.01.717
Goldstein, 2012, Continuous-flow devices and percutaneous site infections: clinical outcomes, J Heart Lung Transplant, 31, 1151, 10.1016/j.healun.2012.05.004
John, 2014, Drive-line infections and sepsis in patients receiving the HVAD system as a left ventricular assist device, J Heart Lung Transplant, 33, 1066, 10.1016/j.healun.2014.05.010
Angud, 2015, Left ventricular assist device driveline infections: the Achilles' heel of destination therapy, AACN Adv Crit Care, 26, 300, 10.1097/NCI.0000000000000108
Wus, 2015, Left ventricular assist device driveline infection and the frequency of dressing change in hospitalized patients, Heart Lung, 44, 225, 10.1016/j.hrtlng.2015.02.001
Hieda, 2014, Importance of early appropriate intervention including antibiotics and wound care for device-related infection in patients with left ventricular assist device, Transplant Proc, 46, 907, 10.1016/j.transproceed.2013.11.106
Nienaber, 2013, Clinical manifestations and management of left ventricular assist device-associated infections, Clin Infect Dis, 57, 1438, 10.1093/cid/cit536
Sperry, 2014, Late manifestation of a driveline infection after heart transplantation, J Heart Lung Transplant, 33, 324, 10.1016/j.healun.2013.12.018
Walter, 2014, Eradication of a chronic wound and driveline infection after redo-LVAD implantation, J Cardiothorac Surg, 9, 63., 10.1186/1749-8090-9-63
Maniar, 2011, Left ventricular assist device-related infections: past, present and future, Expert Rev Med Devices, 8, 627, 10.1586/erd.11.36
Cagliostro, 2016, Continuous-flow left ventricular assist devices and usefulness of a standardized strategy to reduce drive-line infections, J Heart Lung Transplant, 35, 108, 10.1016/j.healun.2015.06.010
Trachtenberg, 2015, A review of infections in patients with left ventricular assist devices: prevention, diagnosis and management, Methodist Debakey Cardiovasc J, 11, 28, 10.14797/mdcj-11-1-28
Yarboro, 2014, Technique for minimizing and treating driveline infections, Ann Cardiothorac Surg, 3, 557
Leuck, 2015, Left ventricular assist device driveline infections: recent advances and future goals, J Thorac Dis, 7, 2151
Lampert, 2014, Blood pressure control in continuous flow left ventricular assist devices: efficacy and impact on adverse events, Ann Thorac Surg, 97, 139, 10.1016/j.athoracsur.2013.07.069
Castagna, 2017, Non-invasive measurement of peripheral, central and 24-hour blood pressure in patients with continuous-flow left ventricular assist device, J Heart Lung Transplant, 36, 694, 10.1016/j.healun.2017.02.026
Bennett, 2015, Blood pressure management in mechanical circulatory support, J Thorac Dis, 7, 2125
Saeed, 2015, Blood pressure and adverse events during continuous flow left ventricular assist device support, Circ Heart Fail, 8, 551, 10.1161/CIRCHEARTFAILURE.114.002000
Lanier, 2013, Validity and reliability of a novel slow cuff-deflation system for noninvasive blood pressure monitoring in patients with continuous-flow left ventricular assist device, Circ Heart Fail, 6, 1005, 10.1161/CIRCHEARTFAILURE.112.000186
Bennett, 2010, Ideal methodology to assess systemic blood pressure in patients with continuous-flow left ventricular assist devices, J Heart Lung Transplant, 29, 593, 10.1016/j.healun.2009.11.604
Wasson, 2015, Hypertension: an unstudied potential risk factor for adverse outcomes during continuous flow ventricular assist device support, Heart Fail Rev, 20, 317, 10.1007/s10741-014-9458-3
Patil, 2016, Does postoperative blood pressure influence development of aortic regurgitation following continuous-flow left ventricular assist device implantation?, Eur J Cardiothorac Surg, 49, 788, 10.1093/ejcts/ezv221
Milano, 2018, HVAD: the ENDURANCE supplemental trial, JACC: Heart Failure, 6, 792
2012, CMA Driver’s Guide: Determining Medical Fitness to Operate Motor Vehicles, 8
Simpson, 2004, Assessment of the cardiac patient for fitness to drive: drive subgroup executive summary, Can J Cardiol, 20, 1314
Emani, 2011, 190 Driver's education: a single center experience on the incidence and safety of driving with LVADS, J Heart Lung Transplant, 30, S70., 10.1016/j.healun.2011.01.197
McKelvie, 2011, The 2011 Canadian Cardiovascular Society heart failure management guidelines update: focus on sleep apnea, renal dysfunction, mechanical circulatory support, and palliative care, Can J Cardiol, 27, 319, 10.1016/j.cjca.2011.03.011
Ambardekar, 2011, Driving with a driveline: a survey of current practice patterns for allowing a patient supported with a left ventricular assist device to drive, J Heart Lung Transplant, 30, 1204, 10.1016/j.healun.2011.06.002
Baskett, 2012, Canadian Cardiovascular Society focused position statement update on assessment of the cardiac patient for fitness to drive: fitness following left ventricular assist device implantation, Can J Cardiol, 28, 137, 10.1016/j.cjca.2011.11.017
Hanke, 2018, Driving after left ventricular assist device implantation, Artif Organs, 42, 695, 10.1111/aor.13130
Dandel, 2011, Heart failure reversal by ventricular unloading in patients with chronic cardiomyopathy: criteria for weaning from ventricular assist devices, Eur Heart J, 32, 1148, 10.1093/eurheartj/ehq353
Segan, 2017, Exercise hemodynamics as a predictor of myocardial recovery in LVAD patients, ASAIO J, 63, 342, 10.1097/MAT.0000000000000490
Pan, 2015, Incidence and predictors of myocardial recovery on long-term left ventricular assist device support: results from the United Network for organ sharing database, J Heart Lung Transplant, 34, 1624, 10.1016/j.healun.2015.08.004
Chaggar, 2016, Myocardial recovery with mechanical circulatory support, Eur J Heart Fail, 18, 1220, 10.1002/ejhf.575
Drakos, 2017, Advancing the science of myocardial recovery with mechanical circulatory support: A Working Group of the National, Heart, Lung, and Blood Institute, J Thorac Cardiovasc Surg, 154, 165, 10.1016/j.jtcvs.2017.03.033
Birks, 2011, Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: a prospective study, Circulation, 123, 381, 10.1161/CIRCULATIONAHA.109.933960
Jakovljevic, 2017, Left ventricular assist device as a bridge to recovery for patients with advanced heart failure, J Am Coll Cardiol, 69, 1924, 10.1016/j.jacc.2017.02.018
Cavigelli-Brunner, 2014, VAD as bridge to recovery in anthracycline-induced cardiomyopathy and HHV6 myocarditis, Pediatrics, 134, E894, 10.1542/peds.2013-2272
Topkara, 2016, Myocardial recovery in patients receiving contemporary left ventricular assist devices: results from the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS), Circ Heart Fail, 9, 1, 10.1161/CIRCHEARTFAILURE.116.003157
Lenneman, 2014, Treatment strategies for myocardial recovery in heart failure, Current Treatment Options in Cardiovascular Medicine, 16, 287., 10.1007/s11936-013-0287-9
Ankersmit, 2006, Recovery from giant cell myocarditis with ECMO support and utilisation of polyclonal antithymocyte globulin: a case report, Thorac Cardiovasc Surg, 54, 278, 10.1055/s-2006-923803
Wiedemann, 2017, Myocardial recovery in peripartum cardiomyopathy after hyperprolactinemia treatment on BIVAD, ASAIO J, 63, 109, 10.1097/MAT.0000000000000452
Birks, 2018, Outcome and primary endpoint results from a prospective multi-center study of myocardial recovery using LVADs: remission from Stage D Heart Failure (RESTAGE-HF), J Heart Lung Transplant, 37, S142., 10.1016/j.healun.2018.01.342
Potapov, 2011, Percutaneous balloon occlusion of a left ventricular assist device outflow cannula to facilitate evaluation of myocardial recovery, J Heart Lung Transplant, 30, 1300, 10.1016/j.healun.2011.07.007
Knierim, 2018, Outcomes from a recovery protocol for patients with continuous-flow left ventricular assist devices, J Heart Lung Transplant
Baldwin, 2016, Surgical approach to continuous-flow left ventricular assist device explantation: a comparison of outcomes, J Thorac Cardiovasc Surg, 151, 192, 10.1016/j.jtcvs.2015.08.024
MacGowan, 2017, Myocardial recovery strategy with decommissioning for the HeartWare left ventricular assist device, ASAIO J, 63, 299, 10.1097/MAT.0000000000000523
Segura, 2014, Granulomatous myocarditis in severe heart failure patients undergoing implantation of a left ventricular assist device, Cardiovasc Pathol, 23, 17, 10.1016/j.carpath.2013.06.005
Roberts, 2009, Cardiac transplantation for cardiac sarcoidosis with initial diagnosis by examination of the left ventricular apical “core” excised for insertion of a left ventricular assist device for severe chronic heart failure, Am J Cardiol, 103, 110, 10.1016/j.amjcard.2008.08.053
Maybaum, 2007, Cardiac improvement during mechanical circulatory support—a prospective multicenter study of the LVAD working group, Circulation, 115, 2497, 10.1161/CIRCULATIONAHA.106.633180
Patel, 2013, Combining neurohormonal blockade with continuous-flow left ventricular assist device support for myocardial recovery: a single-arm prospective study, J Heart Lung Transplant, 32, 305, 10.1016/j.healun.2012.11.019
Selzman, 2015, Bridge to removal: a paradigm shift for left ventricular assist device therapy, Ann Thorac Surg, 99, 360, 10.1016/j.athoracsur.2014.07.061
Liang, 2005, Prediction of cardiac function after weaning from ventricular assist devices, J Thorac Cardiovasc Surg, 130, 1555, 10.1016/j.jtcvs.2005.08.020
Kormos, 2017, Left ventricular assist device malfunctions: it is more than just the pump, Circulation, 136, 1714, 10.1161/CIRCULATIONAHA.117.027360
Potapov, 2012, Pump exchange for cable damage in patients supported with HeartMate II left ventricular assist device, ASAIO J, 58, 578, 10.1097/MAT.0b013e3182703718
Cubillo, 2014, Emergent reconnection of a transected left ventricular assist device driveline, J Emerg Med, 47, 546, 10.1016/j.jemermed.2014.07.028
Duero Posada, 2017, Outflow graft occlusion of the heartmate 3 left ventricular assist device, Circ Heart Fail, 10, 1, 10.1161/CIRCHEARTFAILURE.117.004275
Potapov, 2018, Strategy for surgical correction and mitigation of outflow graft twist with a centrifugal-flow left ventricular assist system, J Heart Lung Transplant, 37, 670, 10.1016/j.healun.2018.03.014
Uriel, 2012, Development of a novel echocardiography ramp test for speed optimization and diagnosis of device thrombosis in continuous-flow left ventricular assist devices: the Columbia ramp study, J Am Coll Cardiol, 60, 1764, 10.1016/j.jacc.2012.07.052
Scandroglio, 2016, Diagnosis and treatment algorithm for blood flow obstructions in patients with left ventricular assist device, J Am Coll Cardiol, 67, 2758, 10.1016/j.jacc.2016.03.573
Uriel, 2015, Left ventricular decompression during speed optimization ramps in patients supported by continuous-flow left ventricular assist devices: device-specific performance characteristics and impact on diagnostic algorithms, J Card Fail, 21, 785, 10.1016/j.cardfail.2015.06.010
Luc, 2018, Medical therapy compared with surgical device exchange for left ventricular assist device thrombosis: a systematic review and meta-analysis, ASAIO J
Centofanti, 2017, Thrombosis in left ventricular assistance device with centrifugal technology: is early thrombolysis a better solution?, Int J Artif Organs, 40, 629, 10.5301/ijao.5000626
Stulak, 2015, Treatment of device thrombus in the HeartWare HVAD: success and outcomes depend significantly on the initial treatment strategy, J Heart Lung Transplant, 34, 1535, 10.1016/j.healun.2015.10.020
Hanke, 2016, Aortic outflow graft stenting in patient with left ventricular assist device outflow graft thrombosis, Artif Organs, 40, 414, 10.1111/aor.12569
Goldstein, 2015, Gastrointestinal bleeding in recipients of the HeartWare ventricular assist system, JACC Heart Fail, 3, 303, 10.1016/j.jchf.2014.11.008
Dakik, 2016, The diagnostic yield of repeated endoscopic evaluation in patients with gastrointestinal bleeding and left ventricular assist devices, Dig Dis Sci, 61, 1603, 10.1007/s10620-015-4028-7
Rennyson, 2013, Octreotide for left ventricular assist device-related gastrointestinal hemorrhage: can we stop the bleeding?, ASAIO J, 59, 450, 10.1097/MAT.0b013e318295232d
Coutance, 2014, Octreotide for recurrent intestinal bleeding due to ventricular assist device, Asian Cardiovasc Thorac Ann, 22, 350, 10.1177/0218492312474902
Katz, 2015, Safety of reduced anti-thrombotic strategies in HeartMate II patients: a one-year analysis of the US-TRACE Study, J Heart Lung Transplant, 34, 1542, 10.1016/j.healun.2015.06.018
Teuteberg, 2015, The HVAD left ventricular assist device: risk factors for neurological events and risk mitigation strategies, JACC Heart Fail, 3, 818, 10.1016/j.jchf.2015.05.011
Nassif, 2015, Systolic blood pressure on discharge after left ventricular assist device insertion is associated with subsequent stroke, J Heart Lung Transplant, 34, 503, 10.1016/j.healun.2014.09.042
Garan, 2015, Early post-operative ventricular arrhythmias in patients with continuous-flow left ventricular assist devices, J Heart Lung Transplant, 34, 1611, 10.1016/j.healun.2015.05.018
Baldwin, 2017, Tolerance of sustained ventricular fibrillation during continuous-flow left ventricular assist device support, Tex Heart Inst J, 44, 357, 10.14503/THIJ-16-5879
Garan, 2013, Ventricular arrhythmias and implantable cardioverter-defibrillator therapy in patients with continuous-flow left ventricular assist devices: need for primary prevention?, J Am Coll Cardiol, 61, 2542, 10.1016/j.jacc.2013.04.020
Cantillon, 2010, Improved survival among ventricular assist device recipients with a concomitant implantable cardioverter-defibrillator, Heart Rhythm, 7, 466, 10.1016/j.hrthm.2009.12.022
Stulak, 2017, Percutaneous driveline fracture after implantation of the heartmate ii left ventricular assist device: how durable is driveline repair?, ASAIO J, 63, 542, 10.1097/MAT.0000000000000531
Goldstein, 2013, Algorithm for the diagnosis and management of suspected pump thrombus, J Heart Lung Transplant, 32, 667, 10.1016/j.healun.2013.05.002
Bartoli, 2014, Hematologic markers better predict left ventricular assist device thrombosis than echocardiographic or pump parameters, Thorac Cardiovasc Surg, 62, 414, 10.1055/s-0034-1376891
Potapov, 2015, Cerebral protection system applied during washout of thrombus occluding inflow cannula of HeartWare HVAD left ventricular assist device, J Heart Lung Transplant, 34, 1640, 10.1016/j.healun.2015.10.017
Hubbert, 2017, Endovascular stenting of a LVAD outflow graft thrombosis, ASAIO J, 63, e3, 10.1097/MAT.0000000000000371
Kemaloglu, 2018, First successful percutaneous treatment of a totally occluded HeartWare outflow graft: case report and literature review, Anatol J Cardiol, 19, 341
Wiedemann, 2018, Interventional treatment of LVAD outflow graft stenosis by introduction of bare metal stents, ASAIO J, 64, e3, 10.1097/MAT.0000000000000547
Bhamidipati, 2017, Outflow graft obstruction treated with transcatheter management: a novel therapy for a new diagnosis, Ann Thorac Surg, 103, e101, 10.1016/j.athoracsur.2016.07.031
Linneweber, 2007, The effect of surface roughness on activation of the coagulation system and platelet adhesion in rotary blood pumps, Artif Organs, 31, 345, 10.1111/j.1525-1594.2007.00391.x
Heilmann, 2017, Acquired Von Willebrand syndrome in patients on long-term support with HeartMate II, Eur J Cardiothorac Surg, 51, 587
Geisen, 2008, Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease, Eur J Cardiothorac Surg, 33, 679, 10.1016/j.ejcts.2007.12.047
Powers, 2018, 2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association, Stroke, 49, e46, 10.1161/STR.0000000000000158
Rimsans, 2018, Four factor prothrombin complex concentrate for warfarin reversal in patients with left ventricular assist devices, J Thromb Thrombolysis, 46, 180, 10.1007/s11239-018-1680-8
Willey, 2016, Outcomes after stroke complicating left ventricular assist device, J Heart Lung Transplant, 35, 1003, 10.1016/j.healun.2016.03.014
Clerkin, 2017, The role of implantable cardioverter defibrillators in patients bridged to transplantation with a continuous-flow left ventricular assist device: a propensity score matched analysis, J Heart Lung Transplant, 36, 633, 10.1016/j.healun.2016.11.008
Soleimani, 2012, Development of aortic insufficiency in patients supported with continuous flow left ventricular assist devices, ASAIO J, 58, 326, 10.1097/MAT.0b013e318251cfff
Saito, 2016, Aortic valve pathology in patients supported by continuous-flow left ventricular assist device, Circ J, 80, 1371, 10.1253/circj.CJ-15-1188
Gasparovic, 2017, De novo aortic regurgitation after continuous-flow left ventricular assist device implantation, Ann Thorac Surg, 104, 704, 10.1016/j.athoracsur.2017.01.114
Atkins, 2013, Surgical correction of aortic valve insufficiency after left ventricular assist device implantation, J Thorac Cardiovasc Surg, 146, 1247, 10.1016/j.jtcvs.2013.05.019
Parikh, 2013, Percutaneous transcatheter aortic valve closure successfully treats left ventricular assist device-associated aortic insufficiency and improves cardiac hemodynamics, JACC Cardiovasc Interv, 6, 84, 10.1016/j.jcin.2012.08.021
Russo, 2012, Percutaneous transcatheter closure of the aortic valve to treat cardiogenic shock in a left ventricular assist device patient with severe aortic insufficiency, Ann Thorac Surg, 94, 985, 10.1016/j.athoracsur.2012.01.089
Cowger, 2014, Consequences of aortic insufficiency during long-term axial continuous-flow left ventricular assist device support, J Heart Lung Transplant, 33, 1233, 10.1016/j.healun.2014.06.008
Phan, 2017, Percutaneous transcatheter interventions for aortic insufficiency in continuous-flow left ventricular assist device patients: a systematic review and meta-analysis, ASAIO J, 63, 117, 10.1097/MAT.0000000000000447
Cowger, 2010, The development of aortic insufficiency in left ventricular assist device-supported patients, Circ Heart Fail, 3, 668, 10.1161/CIRCHEARTFAILURE.109.917765
Sayer, 2017, The hemodynamic effects of aortic insufficiency in patients supported with continuous-flow left ventricular assist devices, J Card Fail, 23, 545, 10.1016/j.cardfail.2017.04.012
Retzer, 2016, Predictors of survival following trans-catheter aortic valve closure for left ventricular assist device associated aortic insufficiency, Catheter Cardiovasc Interv, 87, 971, 10.1002/ccd.26280
D'Ancona, 2012, TAVI for pure aortic valve insufficiency in a patient with a left ventricular assist device, Ann Thorac Surg, 93, e89, 10.1016/j.athoracsur.2011.11.019
Santini, 2012, First successful management of aortic valve insufficiency associated with HeartMate II left ventricular assist device support by transfemoral CoreValve implantation, JACC Cardiovasc Interv, 5, 114., 10.1016/j.jcin.2011.10.009
Schechter, 2014, Efficacy and durability of central oversewing for treatment of aortic insufficiency in patients with continuous-flow left ventricular assist devices, J Heart Lung Transplant, 33, 937, 10.1016/j.healun.2014.04.017
Loghmanpour, 2016, A Bayesian model to predict right ventricular failure following left ventricular assist device therapy, JACC Heart Fail, 4, 711, 10.1016/j.jchf.2016.04.004
Takeda, 2015, Incidence and clinical significance of late right heart failure during continuous-flow left ventricular assist device support, J Heart Lung Transplant, 34, 1024, 10.1016/j.healun.2015.03.011
Uriel, 2017, Clinical hemodynamic evaluation of patients implanted with a fully magnetically levitated left ventricular assist device (HeartMate 3), J Heart Lung Transplant, 36, 28, 10.1016/j.healun.2016.07.008
Tedford, 2008, PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support, Circ Heart Fail, 1, 213, 10.1161/CIRCHEARTFAILURE.108.796789
Haglund, 2014, Are peripherally inserted central catheters associated with increased risk of adverse events in status 1B patients awaiting transplantation on continuous intravenous milrinone?, J Card Fail, 20, 630, 10.1016/j.cardfail.2014.06.004
Mermel, 2009, Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America, Clin Infect Dis, 49, 1, 10.1086/599376
Aslam, 2018, Bloodstream infections in mechanical circulatory support device recipients in the International Society of Heart and Lung Transplantation Mechanically Assisted Circulation Support Registry: epidemiology, risk factors, and mortality, J Heart Lung Transplant, 37, 1013, 10.1016/j.healun.2018.04.006
Hooton, 2010, Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 international clinical practice guidelines from the Infectious Diseases Society of America, Clin Infect Dis, 50, 625, 10.1086/650482
Walker, 2011, Surgical infection prophylaxis for left ventricular assist device implantation, J Card Surg, 26, 440, 10.1111/j.1540-8191.2011.01262.x
Kusne, 2013, Infection control and prevention practices for mechanical circulatory support: an international survey, J Heart Lung Transplant, 32, S182., 10.1016/j.healun.2013.01.437
Lazar, 2016, Prevention and management of sternal wound infections, J Thorac Cardiovasc Surg, 152, 962, 10.1016/j.jtcvs.2016.01.060
Bratzler, 2013, Clinical practice guidelines for antimicrobial prophylaxis in surgery, Am J Health Syst Pharm, 70, 195, 10.2146/ajhp120568
Engelman, 2007, The society of thoracic surgeons practice guideline series: antibiotic prophylaxis in cardiac surgery, part II: antibiotic choice, Ann Thorac Surg, 83, 1569, 10.1016/j.athoracsur.2006.09.046
Sousa-Uva, 2018, 2017 EACTS Guidelines on perioperative medication in adult cardiac surgery, Eur J Cardiothorac Surg, 53, 5, 10.1093/ejcts/ezx314
O'Grady, 2011, Guidelines for the prevention of intravascular catheter-related infections, Clin Infect Dis, 52, e162, 10.1093/cid/cir257
Marsteller, 2012, A multicenter, phased, cluster-randomized controlled trial to reduce central line-associated bloodstream infections in intensive care units*, Crit Care Med, 40, 2933, 10.1097/CCM.0b013e31825fd4d8
Platt, 1982, Mortality associated with nosocomial urinary-tract infection, N Engl J Med, 307, 637, 10.1056/NEJM198209093071101
Rustemeyer, 2007, Necessity of surgical dental foci treatment prior to organ transplantation and heart valve replacement, Clin Oral Invest, 11, 171, 10.1007/s00784-007-0101-8
Kallen, 2005, Perioperative intranasal mupirocin for the prevention of surgical-site infections: systematic review of the literature and meta-analysis, Infect Control Hosp Epidemiol, 26, 916, 10.1086/505453
Hebert, 2010, Decolonization therapy in infection control, Curr Opin Infect Dis, 23, 340, 10.1097/QCO.0b013e32833ae214
Holman, 1999, Infection during circulatory support with ventricular assist devices, Ann Thorac Surg, 68, 711, 10.1016/S0003-4975(99)00529-9
Aslam, 2010, Risk factors and outcomes of fungal ventricular-assist device infections, Clin Infect Dis, 50, 664, 10.1086/650454
Classen, 1992, The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection, N Engl J Med, 326, 281, 10.1056/NEJM199201303260501
Baronetto, 2014, A simple device to secure ventricular assist device driveline and prevent exit-site infection, Interact CardioVasc Thorac Surg, 18, 415, 10.1093/icvts/ivt549
Barber, 2015, A simple education tool for ventricular assist device patients and their caregivers, J Cardiovasc Nurs, 30, E1, 10.1097/JCN.0000000000000122
Wilson, 2007, Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group, Circulation, 116, 1736, 10.1161/CIRCULATIONAHA.106.183095
Baddour, 2003, Nonvalvular cardiovascular device-related infections, Circulation, 108, 2015, 10.1161/01.CIR.0000093201.57771.47
Dell'Aquila, 2016, Contributory role of fluorine 18-fluorodeoxyglucose positron emission tomography/computed tomography in the diagnosis and clinical management of infections in patients supported with a continuous-flow left ventricular assist device, Ann Thorac Surg, 101, 87, 10.1016/j.athoracsur.2015.06.066
Tlili, 2014, The usefulness of FDG PET/CT imaging in suspicion of LVAD infection, J Nucl Cardiol, 21, 845, 10.1007/s12350-014-9872-x
Slaughter, 2010, Clinical management of continuous-flow left ventricular assist devices in advanced heart failure, J Heart Lung Transplant, 29, S1, 10.1016/j.healun.2010.01.011
Pereda, 2011, Left ventricular assist device driveline infections, Cardiol Clin, 29, 515, 10.1016/j.ccl.2011.08.004
Lee, 2001, Difficulties in anticoagulation management during coadministration of warfarin and rifampin, Pharmacotherapy, 21, 1240, 10.1592/phco.21.15.1240.33897
Dew, 1999, Quality of life outcomes in left ventricular assist system inpatients and outpatients, ASAIO J, 45, 218, 10.1097/00002480-199905000-00022
Wordingham, 2017, Palliative care clinicians caring for patients before and after continuous flow-left ventricular assist device, J Pain Symptom Manage, 54, 601, 10.1016/j.jpainsymman.2017.07.007
Warraich, 2017, How medicine has changed the end of life for patients with cardiovascular disease, J Am Coll Cardiol, 70, 1276, 10.1016/j.jacc.2017.07.735
Bayoumi, 2017, Palliative care in cardiac transplantation: an evolving model, Heart Fail Rev, 22, 605, 10.1007/s10741-017-9613-8
Costanzo, 2010, The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients, J Heart Lung Transplant, 29, 914, 10.1016/j.healun.2010.05.034
Jaarsma, 2009, Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology, Eur J Heart Fail, 11, 433, 10.1093/eurjhf/hfp041
Sinha, 2017, Development of a protocol for successful palliative care consultation in population of patients receiving mechanical circulatory support, J Pain Symptom Manage, 54, 583, 10.1016/j.jpainsymman.2017.07.021